LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
Grand Rounds U.S.
Grand Rounds Europe
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Dec 16, 2024
Distillery Therapeutics
Inhibiting FST-IGF1R interaction for neuropathic pain
Read More
BioCentury
|
Nov 27, 2024
Discovery & Translation
Science Spotlight: Reducing immune rejection of stem cell-derived therapies
BioCentury’s roundup of translational innovation also includes a new target for arrhythmia and four papers with links to newcos
Read More
BioCentury
|
Oct 24, 2024
Product Development
Vaderis: A case study in navigating the orphan drug development maze
Company went from idea to clinical proof of concept for
Read More
BioCentury
|
Oct 21, 2024
Product Development
EGFR: A best-in-class strategy study
The target is one of industry’s most notable case studies in continued product differentiation and market growth
Read More
BioCentury
|
Oct 7, 2024
Distillery Therapeutics
Inhibiting CCL7 for diabetic vascular disease
Read More
BioCentury
|
Aug 28, 2024
Product Development
Clinical Report: U.K. details plans to improve clinical trial infrastructure
Plus: Neurocrine’s schizophrenia therapy, Medicxi-backed Vaderis’ treatment for rare vascular disorder both look to advance; plus a miss for Leo’s Timber
Read More
BioCentury
|
Aug 1, 2024
Distillery Therapeutics
PIK3CG-degrading PROTAC for AML
Read More
BioCentury
|
Apr 10, 2024
Finance
How Goldman Sachs’ life sciences strategy aims to scale private biotechs
Recent investment in Alterome is one of six since 2022 intended to allow biotechs to reach milestones while staying private longer
Read More
BioCentury
|
Apr 5, 2024
Finance
Venture report: Nine-digit rounds for Obsidian, Alterome, Diagonal
Plus: Neurosterix launches with a potential competitor to the schizophrenia therapy developed by Karuna
Read More
BioCentury
|
Mar 26, 2024
Distillery Therapeutics
Inhibiting CHREBP for hepatocellular carcinoma
Read More
Items per page:
10
1 - 10 of 674